Logo-ipp

Immunopathol Persa. 2022;8(1): e18. doi: 10.34172/ipp.2022.18

Original

Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

Mohamed M Darwish 1 ORCID, Atef Y Riad 1, Dina A Salem 1, Ahmad E Essa 1, Marwa M Shakweer 2 * ORCID, Diaa Eldin M. Sherif 1

Cited by CrossRef: 8

1- Arabpour J, Rezaei K, Khojini J, Razi S, Hayati M, Gheibihayat S. The potential role and mechanism of circRNAs in Ferroptosis: A comprehensive review. Pathology - Research and Practice. 2024;255:155203 [Crossref]
2- Haghighi S, Ghaderian S, Rakhshan A, Motamed N. Evaluation of the Expression of miRNAs, LncRNAs, and their Target Gene, Caspase 3 in Glioblastoma Multiform: A Case–Control Study. Mol Biotechnol. 2023;65(9):1444 [Crossref]
3- Kardooni A, Bahrampour A, Golmohammadi S, Jalili A, Alishahi M. The Role of Epithelial Mesenchymal Transition (EMT) in Pathogenesis of Cardiotoxicity: Diagnostic & Prognostic Approach. Mol Biotechnol. 2023;65(9):1403 [Crossref]
4- Mondal S, Bhattacharya S, Sarkar A, Saha R. Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance. 2023;19(Suppl 1):S81 [Crossref]
5- Ranapour S, Motamed N. Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines. Mol Biotechnol. 2023;65(12):1979 [Crossref]
6- Saastad S, Skjervold A, Ytterhus B, Engstrøm M, Bofin A. PD-L1 protein expression in breast cancer. J Clin Pathol. 2024;77(11):730 [Crossref]
7- Ghasemi Darestani N, Gilmanova A, Al-Gazally M, Zekiy A, Ansari M, Zabibah R, Jawad M, Al-Shalah S, Rizaev J, Alnassar Y, Mohammed N, Mustafa Y, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023;21(1) [Crossref]
8- Bao S, Darvishi M, H Amin A, Al-Haideri M, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-qaim Z, Al-Gazally M, Kiasari B, Tavakoli-Far B, Sidikov A, Mustafa Y, Akhavan-Sigari R. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. J Cancer Res Clin Oncol. 2023;149(10):7945 [Crossref]
9- Yang M, Zhang Y, Li M, Liu X, Darvishi M. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. Cancer Cell Int. 2023;23(1) [Crossref]